Mission Creek Capital Partners’s Health Catalyst HCAT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2020
Q2
Sell
-42,137
Closed -$1.1M 174
2020
Q1
$1.1M Buy
+42,137
New +$1.29M 0.59% 41

Other funds holding HCAT

Mission Creek Capital Partners's HCAT Position: Q2 2020 in Review

Mission Creek Capital Partners sold out of Health Catalyst (HCAT) in Q2 2020, closing a stake of 42,137 shares — an estimated $1.1M sold.

Mission Creek Capital Partners first reported a position in HCAT in Q1 2020 and held it in 1 quarter. The position peaked at $1.1M in Q1 2020. 128 funds tracked by Wall St. Rank hold HCAT as of Q2 2020.

  • Mission Creek Capital Partners reported no remaining Health Catalyst position as of Q2 2020 after selling out during the quarter.
  • Mission Creek Capital Partners sold 42,137 Health Catalyst shares in Q2 2020, an estimated $1.1M.
  • Mission Creek Capital Partners first reported a position in Health Catalyst in Q1 2020 and held it in 1 quarter.
  • Mission Creek Capital Partners's Health Catalyst position peaked at $1.1M in Q1 2020.
  • 128 funds tracked by Wall St. Rank held Health Catalyst as of Q2 2020.

Based on Mission Creek Capital Partners's 13F filing for Q2 2020, filed 14 Aug 2020.